The Bombay Burmah Trading Corporation Q2 Results 2026: PAT ₹610 Cr
Q2 FY27 results statement: what the company reported on revenue, margins and capex.
- Revenue
- ₹5,698Cr
- +15.3% YoY
- +12% QoQ
- Net profit
- ₹610Cr
- +7.7% YoY
- +4.6% QoQ
- Margin
- 17.6%
- −1.4 pp YoY
- +1.5 pp QoQ
Top 10 Food Products companies on management guidance
See the sector's top 10 — free with your mobile number.
The Bombay Burmah Trading Corporation Ltd Q2 FY27 key numbers
- Revenue
- Revenue from operations (consolidated) for the quarter ended 30 September 2026: ₹5,797.81 crores.
As stated in The Bombay Burmah Trading Corporation Ltd's Q2 FY27 results statement · published 13 Nov 2026. Reported figures, not investment advice.
Based on The Bombay Burmah Trading Corporation Ltd's Q2 FY27 results statement. The company has not published an earnings-call transcript for this quarter, so figures here are what the results statement reports, not management guidance.
The short version
Revenue from operations (consolidated) for the quarter ended 30 September 2026: ₹5,797.81 crores (Page 15).
From The Bombay Burmah Trading Corporation Ltd's Q2 FY27 earnings-call transcript · updated 13 Nov 2026.
How did The Bombay Burmah Trading Corporation's revenue grow in the September 2026 quarter?
- Revenue from operations (consolidated) for the quarter ended 30 September 2026: ₹5,797.81 crores (Page 15).
- Revenue from operations for the quarter ended 30 September 2025: ₹5,024.27 crores (Page 15).
- Year-on-year revenue increase: ₹5,797.81 crores vs ₹5,024.27 crores, approx. 15.4% growth.
- Segment-wise revenue highlights for the quarter 30/09/2026 vs 30/09/2025 (in ₹ crores):
- Plantations (Tea): 14.46 vs 18.42 (decrease)
- Auto electrical components: 52.63 vs 53.38 (slight decrease)
- Investments: 1,175.04 vs 952.21 (significant increase)
- Healthcare: 11.28 vs 9.41 (increase)
2 more points from The Bombay Burmah Trading Corporation Ltd's call on revenue
Create a free account to keep reading this call
What happened to The Bombay Burmah Trading Corporation's margins in Q2 FY27?
See what The Bombay Burmah Trading Corporation Ltd said on profitability & margins — free account, 30 seconds.
What capex is The Bombay Burmah Trading Corporation planning?
See what The Bombay Burmah Trading Corporation Ltd said on capital expenditure plans — free account, 30 seconds.
Top-ranked in Food Products
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Is The Bombay Burmah Trading Corporation raising money or cutting debt?
The presentation mentions no direct equity fundraising or issuance of shares during the period.
Locked: what The Bombay Burmah Trading Corporation Ltd said on fundraising
Also locked on this page: margins, capex
Free account, 30 seconds. No card needed.
How big is The Bombay Burmah Trading Corporation's order book?
The Bombay Burmah Trading Corporation Ltd — Quarterly revenue & net profit
The Bombay Burmah Trading Corporation Ltd Q2 FY27 results — key figures
| ₹ Cr | Q2 FY27 | Q2 FY26 | YoY | Q1 FY27 | QoQ |
|---|---|---|---|---|---|
| Revenue | 5,698 | 4,943 | +15.3% | 5,089 | +12% |
| Operating profit (EBITDA) | 1,005 | 939 | +7.1% | 819 | +22.7% |
| Operating margin | 17.6% | 19% | -1.4 pp | 16.1% | +1.5 pp |
| Profit before tax | 983 | 893 | +10% | 792 | +24.1% |
| Net profit (PAT) | 610 | 566 | +7.7% | 583 | +4.6% |
| EPS (₹) | 35.56 | 34.64 | +2.7% | 41.31 | -13.9% |
Source: The Bombay Burmah Trading Corporation Ltd's results filing to NSE (consolidated), ₹ crore.
Reported quarterly figures (₹ Cr). Latest (Q2 FY27): revenue ₹5.7K Cr, net profit ₹610 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →More Q2 FY27 results in Food Products
Continue your research
What The Bombay Burmah's management said in earlier quarters
Others in Food Products this season
- EID Parry (Q2 FY27)
Sugar Segment Q2 FY27 revenue: ₹486 Cr, up 32% from ₹368 Cr in Q2 FY26; sales volume increased from 118.8k MT to 172.2k MT. Key results statement takeaways from
- Ajooni Biotech (Q2 FY27)
3,173.51 Lakhs in the quarter ended 30th September 2025, indicating a year-on-year increase of approximately 106%. Key results statement takeaways from Ajooni B
- Venky's (India) (Q2 FY27)
31.7% increase . Key results statement takeaways from Venkys (India) Ltd's Q2 FY27 results statement — and how it ranks against sector peers.
- Apex Frozen Food (Q2 FY27)
Q2FY27 Net Revenue: Rs 2,737 Mn, up 15% YoY from Rs 2,383 Mn in Q2FY26. Key investor presentation takeaways from Apex Frozen Foods Ltd's Q2 FY27 investor presen
Potential multibaggers · Q2 FY27
Potential multibaggers in Food Products
on management's own guidance
- Strong growth2
- Strong growth1
- Strong growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Arthneeti Pro · Annual
The Bombay Burmah Trading Corporation Ltd and 15K+ more earnings calls,
for less than your morning chai
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were The Bombay Burmah Trading Corporation Ltd Q2 FY27 results?
Revenue from operations (consolidated) for the quarter ended 30 September 2026: ₹5,797.81 crores (Page 15).
What is The Bombay Burmah Trading Corporation Ltd share price analysis?
The Bombay Burmah Trading Corporation Ltd currently shows a neutral. The stock trades at a P/E of 7.3 with a market cap of ₹9,023 Cr. Investors should review the full earnings analysis for detailed insights.
Keep The Bombay Burmah Trading Corporation Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's results statement. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.